Skip to content

Clinical trials

Phase 2/3 Myositis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myositis Phase: Phase 2/3 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20141
20151
20171
20211
20221
20232
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abcuro, Inc.1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Ashibio Inc1
Cabaletta Bio1
Karolinska Institutet1
National Institute of Environmental Health Sciences (NIEHS)1
Northwell Health1
Novartis Pharmaceuticals1
Restem, LLC.1
Richard Barohn, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myositis13
Dermatomyositis8
Polymyositis5
Myositis, Inclusion Body4
Muscular Diseases2
Autoimmune Diseases1
Calcinosis1
Connective Tissue Diseases1
Hallux Valgus1
Inflammation1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.